REGISTER now for FREE 
|
FREE patent keyword monitoring and additional FREE benefits. REGISTER now for FREE
|
|
|
Browse: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | 1 | 3 | Chiron Corporation Intellectual Property - R440 patentsThe following is a sampling of recent Chiron Corporation Intellectual Property - R440 patent applications (USPTO Patent Application #, Patent Title) sorted by month.September 2008 - Chiron Corporation Intellectual Property - R440 patents 20080214481 - Methods of treatment of endobronchial infections April 2008 - Chiron Corporation Intellectual Property - R440 patents 20080095717 - Methods and unit dose formulations for the inhalation administration of aminoglycoside antibiotics March 2008 - Chiron Corporation Intellectual Property - R440 patents 20080069817 - Heteroaryl-fused pyrimidinyl compounds as anticancer agents January 2008 - Chiron Corporation Intellectual Property - R440 patents 20080004433 - Characterization of the gsk-3beta protein and methods of use thereof December 2007 - Chiron Corporation Intellectual Property - R440 patents 20070299039 - Substituted benz-azoles and methods of their use as inhibitors of raf kinase 20070293491 - Indazole compounds and methods for inhibition of cdc7 November 2007 - Chiron Corporation Intellectual Property - R440 patents 20070264699 - Method for cyrstallizing human gsk3 and novel crystal structure thereof October 2007 - Chiron Corporation Intellectual Property - R440 patents 20070244109 - Pyrrole based inhibitors of glycogen synthase kinase 3 January 2007 - Chiron Corporation Intellectual Property - R440 patents 20070020745 - Method for crystallizing human gsk3 and novel crystal structure thereof 20070010469 - Gene products differentially expressed in cancerous cells iii November 2006 - Chiron Corporation Intellectual Property - R440 patents 20060269515 - Interleukin-2 muteins 20060269563 - Mutant forms of meningococcal adp-ribosylating toxin 20060263390 - Modified saccharides, conjugates thereof, and their manufacture 20060257852 - Severe acute respiratory syndrome coronavirus 20060258588 - Compositions and methods for treating articular cartilage disorders 20060258849 - Nucleic acids and proteins from streptococcus groups a & b 20060251617 - Methods for treating lymphomas 20060251670 - Multiple variants of meningococcal protein nmb1870 October 2006 - Chiron Corporation Intellectual Property - R440 patents 20060233827 - 85kda neisserial antigen 20060234205 - In vitro test system for predicting patient tolerability of therapeutic agents 20060234233 - Random transposon insertion in staphylococcus aureus and use thereof to identify essential genes 20060234256 - Double stranded rna receptor (dsrna-r) and methods relating thereto 20060235019 - Substituted quinazolinone compounds September 2006 - Chiron Corporation Intellectual Property - R440 patents 20060216308 - Immunisation against chlamydia trachomatis 20060216317 - Delivery of polynucleotide agents to the central nervous system 20060210579 - Nucleic acids and proteins from streptococcus groups a & b 20060210580 - Nucleic acids and proteins from streptococcus groups a & b 20060210581 - Nucleic acids and proteins from streptococcus groups a & b 20060210582 - Nucleic acids and proteins from streptococcus groups a & b ### This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Chiron Corporation Intellectual Property - R440 in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Chiron Corporation Intellectual Property - R440 with additional patents listed. Browse our Agent directory for other possible listings. ### FreshPatents.com Support |